Gliomas Infiltrating the Corpus Callosum: A Systematic Review of the Literature
dc.contributor.author | Palmisciano, Paolo | |
dc.contributor.author | Ferini, Gianluca | |
dc.contributor.author | Watanabe, Gina | |
dc.contributor.author | Ogasawara, Christian | |
dc.contributor.author | Lesha, Emal | |
dc.contributor.author | Bin-Alamer, Othman | |
dc.contributor.author | Umana, Giuseppe E. | |
dc.contributor.author | Yu, Kenny | |
dc.contributor.author | Cohen-Gadol, Aaron A. | |
dc.contributor.author | El Ahmadieh, Tarek Y. | |
dc.contributor.author | Haider, Ali S. | |
dc.contributor.department | Neurological Surgery, School of Medicine | en_US |
dc.date.accessioned | 2023-06-16T13:29:59Z | |
dc.date.available | 2023-06-16T13:29:59Z | |
dc.date.issued | 2022-05-19 | |
dc.description.abstract | Background: Gliomas infiltrating the corpus callosum (G-I-CC) majorly impact patient quality-of-life, but maximally safe tumor resection is challenging. We systematically reviewed the literature on G-I-CC. Methods: PubMed, EMBASE, Scopus, Web of Science, and Cochrane were searched following the PRISMA guidelines to include studies of patients with G-I-CC. Clinicopathological features, treatments, and outcomes were analyzed. Results: We included 52 studies comprising 683 patients. Most patients experienced headache (33%), cognitive decline (18.7%), and seizures (17.7%). Tumors mostly infiltrated the corpus callosum genu (44.2%) with bilateral extension (85.4%) into frontal (68.3%) or parietal (8.9%) lobes. Most G-I-CC were glioblastomas (84.5%) with IDH-wildtype (84.9%) and unmethylated MGMT promoter (53.5%). Resection (76.7%) was preferred over biopsy (23.3%), mostly gross-total (33.8%) and subtotal (32.5%). The tumor-infiltrated corpus callosum was resected in 57.8% of cases. Radiation was delivered in 65.8% of patients and temozolomide in 68.3%. Median follow-up was 12 months (range, 0.1−116). In total, 142 patients (31.8%) experienced post-surgical complications, including transient supplementary motor area syndrome (5.1%) and persistent motor deficits (4.3%) or abulia (2.5%). Post-treatment symptom improvement was reported in 42.9% of patients. No differences in rates of complications (p = 0.231) and symptom improvement (p = 0.375) were found in cases with resected versus preserved corpus callosum. Recurrences occurred in 40.9% of cases, with median progression-free survival of 9 months (0.1−72). Median overall survival was 10.7 months (range, 0.1−116), significantly longer in low-grade tumors (p = 0.013) and after resection (p < 0.001), especially gross-total (p = 0.041) in patients with high-grade tumors. Conclusions: G-I-CC show clinicopathological patterns comparable to other more frequent gliomas. Maximally safe resection significantly improves survival with low rates of persistent complications. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Palmisciano P, Ferini G, Watanabe G, et al. Gliomas Infiltrating the Corpus Callosum: A Systematic Review of the Literature. Cancers (Basel). 2022;14(10):2507. Published 2022 May 19. doi:10.3390/cancers14102507 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/33809 | |
dc.language.iso | en_US | en_US |
dc.publisher | MDPI | en_US |
dc.relation.isversionof | 10.3390/cancers14102507 | en_US |
dc.relation.journal | Cancers | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | PMC | en_US |
dc.subject | Butterfly glioma | en_US |
dc.subject | Corpus callosum | en_US |
dc.subject | Glioblastoma | en_US |
dc.subject | Neuro-oncology | en_US |
dc.subject | Survival | en_US |
dc.title | Gliomas Infiltrating the Corpus Callosum: A Systematic Review of the Literature | en_US |
dc.type | Article | en_US |